Appraisal suspended
Indication |
|
| Status: Suspended | |
Treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines. |
|
Medicine details |
|
| Medicine name | oritavancin (Tenkasi®) |
| Formulation | 400 mg powder for concentrate for solution for infusion |
| Reference number | 5023 |
| Indication | As above |
| Company | Menarini UK |
| BNF chapter | Infections |
| Submission type | Full |
| Status | Suspended |
| NMG meeting date | 02/03/2022 |
| AWMSG meeting date | 27/04/2022 |
| Date of issue | TBC |
| Further information AWMSG position statement on the appraisal of antimicrobial medicines |
|